Montagu and Kohlberg to Acquire Teleflex Medical OEM in a Carve-out Transaction

Key Terms

assets under management financial

Assets under management (AUM) is the total value of all the investments that a financial company or fund is responsible for overseeing on behalf of its clients. It’s like a big bucket that shows how much money the firm is managing for people or organizations. A higher AUM often indicates a larger, more trusted company, and it can influence how much money they earn and the services they can offer.

esg financial

ESG stands for Environmental, Social, and Governance, which are key factors investors consider when evaluating how sustainable and responsible a company is. It involves assessing how a company manages its impact on the environment, treats its employees and communities, and operates transparently and ethically. Investors use ESG criteria to identify businesses that align with their values and have the potential for long-term success.

Leading Medical Device Designer & Manufacturer to Operate as Independent Company Following Closing of Transaction

NEW YORK--(BUSINESS WIRE)-- Montagu and Kohlberg, two leading middle-market private equity firms, today announced that they have entered into a definitive agreement to acquire Teleflex Medical OEM (the “Company”) from Teleflex Incorporated (NYSE: TFX) for $1.5 billion in a carve-out transaction.

For over 40 years, Teleflex Medical OEM has developed and supplied custom-engineered interventional catheter components and sub-assemblies, as well as surgical fibers and sutures, used across fast-growing treatment areas – including structural heart, neurovascular, electrophysiology and urology – that rely on advanced materials and precision manufacturing to improve surgical outcomes and patients’ lives. With seven state-of-the-art facilities across the U.S., Mexico, and Ireland, the Company leverages its complex extrusion expertise, breadth of offering, and vertically integrated operating model to support a blue-chip customer base of medical device companies worldwide.

Following the closing of the transaction, which is expected in the second half of 2026 subject to customary regulatory approvals and other closing conditions, the Company will operate as an independent, global contract developer and manufacturer ideally positioned to bring innovative solutions to market at pace, with the strategic focus and operational flexibility to scale its model. Greg Stotts, who joined Teleflex in 2006 and currently serves as the Company’s President and General Manager, will become Chief Executive Officer of the Company at that time, bringing over three decades of industry sales, marketing, sales operations, and manufacturing experience to his new role.

Mr. Stotts said: “This is a momentous milestone for our team and our customers, and we are excited to work with the Montagu and Kohlberg team to shape the future of Teleflex Medical OEM. As a focused, independent company backed by experienced healthcare investors, we will accelerate investment in innovation, quality systems and capacity while continuing to deliver the reliability and engineering depth our customers expect.”

Montagu and Kohlberg bring leading track records with decades of experience investing in healthcare products and services. The firms’ complementary carve-out and value creation expertise will help to ensure Teleflex Medical OEM seamlessly transitions to an independent company while accelerating its growth by expanding its customer base, investing in innovation, people, processes and capabilities.

Adrien Sassi, Partner at Montagu, added: “We have followed Teleflex Medical OEM for several years, giving us real insight into the caliber of the organization and the opportunity that lies ahead as an independent company. Over the last decade, Teleflex Medical OEM has built a reputation as a leading strategic supplier in the global medtech value chain, known for its engineering support, reliability, and quality. Working with Kohlberg, we look forward to leveraging our carve-out expertise, built through decades of transaction experience, and our strong track record in driving growth acceleration in medical device platforms, to support Greg and his team in unlocking the full potential of the company.”

Matt Jennings, Operating Partner at Kohlberg, will assume the role of Chairman of the Company upon closing of the transaction. Mr. Jennings commented: “Medical device companies are increasingly under pressure to optimize their portfolios and consolidate supply chains to create value for their patients and shareholders. Teleflex Medical OEM has proven itself as a differentiated, integrated, and compliant business uniquely positioned to create long-term mutually beneficial contract development and manufacturing partnerships with customers. We look forward to supporting Greg and the entire Teleflex Medical OEM team to create a bright future for all Company stakeholders as the business scales.”

“Teleflex Medical OEM is an exceptional platform trusted by its customers for its quality, service and delivery,” added Chris Anderson, Senior Partner of Kohlberg. “The Company is ideally suited to benefit from Kohlberg’s expertise supporting market-leading healthcare platforms, drawing on our deep network of operating executives and our ecosystem of investments and industry relationships. We look forward to working with our partners at Montagu, and together we are confident that Teleflex Medical OEM will thrive as a standalone platform focused on delivering maximum value to its customers.”

Raymond James acted as exclusive financial advisor, and Kirkland & Ellis and Ropes & Gray served as legal counsels to Montagu and Kohlberg.

About Teleflex Medical OEM

Teleflex Medical OEM is a leading contract developer and manufacturer of custom-engineered interventional catheter components and sub-assemblies, as well as surgical fibers and sutures. With seven sites across the U.S., Mexico, and Ireland, the Company combines deep materials expertise with vertically integrated manufacturing and dedicated EPIC design centers to help customers bring high-performance medical devices to market.

About Montagu

Montagu is a leading mid-market private equity firm, committed to finding and growing businesses that make the world work. Focusing on businesses with a must-have product or service in a structurally growing marketplace, Montagu brings proven growth capabilities to help companies achieve their ambitions and unlock their full potential. Montagu specializes in carve-out and other first-time buyout investments and has deep expertise in five priority sectors: Healthcare, Financial Sector Services, Critical Data, Digital Infrastructure and Education. ESG forms an integral part of its strategy, and its commitment to responsible investment is fully integrated into its investment and value-creation process. Montagu has €14 billion of assets under management.

For more information, please visit www.montagu.com.

About Kohlberg

Founded in 1987, Kohlberg is a leading U.S. middle market private equity firm based in Mount Kisco, New York. The firm invests in leading healthcare and services companies characterized by strong market positions, recurring revenue streams and resilient end markets, which it identifies through rigorous thematic research grounded in its White Paper Program. Leveraging its team of investment and operating professionals, Kohlberg works with management teams to accelerate growth, enhance operational excellence and create value. As of September 30, 2025, Kohlberg manages approximately $17 billion on behalf of investors globally.

For more information, please visit www.kohlberg.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251208550931/en/

Media enquiries – Montagu

Greenbrook: James Madsen, Cecilie Oerting

+44 20 7952 2000 | montagu@greenbrookadvisory.com



Media enquiries – Kohlberg

Gasthalter & Co.: Amanda Shpiner, Jonathan Warren

+1 212-257-4170 | media@kohlberg.com

Source: Kohlberg